FUJIFILM Holdings Corporation has identified “Health” as one of the priority areas in its corporate social responsibility (CSR) plan “Sustainable Value Plan 2030” ending March 2031. As part of the Company’s health goals, Fujifilm will improve access to healthcare and medicine around the world through our cutting-edge products and services across prevention, diagnosis and treatment.
Fujifilm plans to issue a social bond offering in April 2022. It will be used to finance the Company’s biopharmaceutical contract development and manufacturing business (Bio CDMO business), which contributes to fulfilling unmet medical needs and improving medical accessibility across the globe.
|
|
*Entities that assist with the issuance of Social Bonds by undertaking tasks such as drawing up the framework for the bond issuance and obtaining a second party opinion.